Evidence map›Paper›PMID 32071051›Full record

Trial reportAntimicrobial agents and chemotherapy2020

Gregory G Stone, Patricia A Bradford, Margaret Tawadrous, Dianna Taylor, Mary Jane Cadatal, Zhangjing Chen, Joseph W Chow

Open access · greenAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. New antibiotics targeting Gram-negative bacilli.Le infezioni in medicina · 2025
    Review
  3. Novel Antibiotics for Gram-Negative Nosocomial Pneumonia.Antibiotics (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Anti-Microorganisms · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gregory G StonePfizer, Groton, Connecticut, USA GregoryG.Stone@pfizer.com.
Patricia A BradfordAstraZeneca Pharmaceuticals, Waltham, Massachusetts, USA.
Margaret TawadrousPfizer, Groton, Connecticut, USA.
Dianna TaylorTaylorMade Health, Ltd, Warrington, United Kingdom.
Mary Jane CadatalPfizer, Manila, Philippines.
Zhangjing ChenAstraZeneca, Shanghai, China.
Joseph W ChowPfizer, Collegeville, Pennsylvania, USA.
Pfizer (United States) · USAstraZeneca (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nosocomial pneumonia (NP), including ventilator-associated pneumonia (VAP), is increasingly associated with multidrug-resistant Gram-negative pathogens. This study describes the

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsAzabicyclo Compoundsbeta-Lactamase InhibitorsCeftazidimeDouble-Blind MethodDrug CombinationsFemaleGram-Negative BacteriaGram-Positive BacteriaGram-Positive Bacterial InfectionsHealthcare-Associated PneumoniaHumansAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo Compoundsbeta-Lactamase InhibitorsCeftazidimeDrug Combinationsceftazidime-avibactampneumoniasusceptibility

Identifiers

PMID32071051
PMCPMC7179600
OpenAlexW3008964086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.